← Back to headlines
Pfizer's Hemophilia Therapy Hympavzi Receives European Label Expansion
Pfizer has been granted a label expansion in Europe for its hemophilia therapy, Hympavzi, broadening its approved uses.
13 May, 11:48 — 13 May, 11:48
Sources
Showing 1 of 1 sources
